neurocardiogenic vasopressor dysfunction; neurally-mediated syncope; reflex syncope (NVD)
Jump to navigation
Jump to search
Classification
- vasovagal reaction
- carotid sinus syncope
- situational syncope
- other: vasovagal-type reactions in cardiac transplant patients with denervated hearts
Etiology
- prolonged standing
- orthostatic hypotension
- hypovolemia
- pharmaceutical agents
- autonomic dysfunction
- increased adrenergic or emotional state
- pharmaceutical agents
Epidemiology
- accounts for the majority of syncopal episodes in the general population
Pathology
- usually seen in patients with normal left ventricular function in the absence of structural heart disease
- generally benign condition[3]
Clinical manifestations
- lightheadedness, wooziness
- nausea, warmth, diaphoresis
Diagnostic procedures
- baseline electrocardiogram (routine)
- not routine
- echocardiogram to assess structural heart disease
- event recorder better than HOLTER for capturing rhythm during syncopal event
- tilt-table testing for patients with recurrent syncope & absence of structural heart disease
- useful in patients with LVEF > 40% in whom NVD is suspected, in which delayed orthostatic hypotension develops over 15-45 minutes
Management
- general measures
- adequate hydration
- use caution with changes in postural position
- compression stockings may reduce pooling of blood in lower extremities[6]
- hospitalization generally unnecessary[3]
- reassurance for young patients
- pharmacologic therapy
- beta-blockers (cardioselective {beta-1} best)[1][3]; of no benefit[2]
- disopyramide
- theophylline
- anticholinergic agents
- serotonin reuptake inhibitors
- fludrocortisone may benefit some patients[5]
More general terms
More specific terms
- carotid sinus syndrome; carotid sinus hypersensitivity; carotid sinus syncope
- vasovagal reaction (fainting)
References
- ↑ 1.0 1.1 Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 204
- ↑ 2.0 2.1 Sheldon R et al, Prevention of Syncope Trial (POST): A randomized, placebo- controlled study of metoprolol in the prevention of vasovagal syncope Circulation 2006; 113:1164 PMID: https://www.ncbi.nlm.nih.gov/pubmed/16505178
- ↑ 3.0 3.1 3.2 3.3 Medical Knowledge Self Assessment Program (MKSAP) 14, 16. American College of Physicians, Philadelphia 2006, 2012
- ↑ Duplyakov D, Golovina G, Garkina S, Lyukshina N. Is it possible to accurately differentiate neurocardiogenic syncope from epilepsy? Cardiol J. 2010;17(4):420-7. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20690104
- ↑ 5.0 5.1 Sheldon R, Raj SR, Rose MS et al Fludrocortisone for the Prevention of Vasovagal Syncope. A Randomized, Placebo-Controlled Trial. J Am Coll Cardiol. 2016;68(1):1-9. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27364043 <Internet> http://content.onlinejacc.org/article.aspx?articleid=2530086
Brignole M Finally, a Drug Proves to Be Effective Against Vasovagal Syncope! But Not in All Patients. J Am Coll Cardiol. 2016;68(1):10-12 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27364044 <Internet> http://content.onlinejacc.org/article.aspx?articleid=2530082 - ↑ 6.0 6.1 Geriatric Review Syllabus, 10th edition (GRS10) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2019